Sorrento Therapeutics Inc
(SRNE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Sales | 15,025 | 16,251 | 15,593 | 17,400 | 11,461 |
| Cost of Goods | 8,453 | 5,186 | 13,722 | 8,268 | 5,704 |
| Gross Profit | 6,572 | 11,065 | 1,871 | 9,132 | 5,757 |
| Operating Expenses | 84,258 | 117,595 | 172,221 | 118,843 | 124,822 |
| Operating Income | -77,233 | -106,344 | -169,628 | -109,443 | -118,361 |
| Interest Expense | 2,668 | 1,132 | 2,219 | 792 | 2,314 |
| Other Income | -27,964 | -35,314 | -38,653 | 18,533 | -99,924 |
| Pre-tax Income | -107,865 | -142,790 | -210,500 | -91,702 | -220,599 |
| Income Tax | 671 | 11,468 | -1,814 | -1,015 | -1,050 |
| Net Income Continuous | -108,536 | -154,626 | -227,115 | -90,625 | -219,477 |
| Minority Interests | -13,324 | -15,010 | -3,422 | -1,049 | -718 |
| Net Income | $-95,212 | $-139,616 | $-223,693 | $-89,576 | $-218,759 |
| EPS Basic Total Ops | -0.17 | -0.26 | -0.51 | -0.20 | -0.54 |
| EPS Basic Continuous Ops | -0.20 | -0.28 | -0.51 | -0.20 | -0.54 |
| EPS Diluted Total Ops | -0.17 | -0.26 | -0.51 | -0.20 | -0.54 |
| EPS Diluted Continuous Ops | -0.20 | -0.28 | -0.51 | -0.20 | -0.54 |
| EPS Diluted Before Non-Recurring Items | -0.17 | -0.26 | N/A | -0.20 | -0.31 |
| EBITDA(a) | $-74,416 | $-101,945 | $-250,263 | $-15,305 | $-118,031 |